Immune monitoring of malignant glioma patients treated with WT1 Trio peptide-based cancer immunotherapy

被引：0
|
作者：
Kanegae, Mizuki [1 ]
Kagawa, Naoki [1 ]
Kijima, Noriyuki [2 ]
Hirayama, Ryuichi [2 ]
Shimokado, Haruka [1 ,2 ]
Nishida, Sumiyuki [3 ]
Hosen, Naoki [4 ]
Tsuboi, Akihiro [5 ]
Oka, Yoshihiro [6 ]
Sugiyama, Haruo [7 ]
Kishima, Haruhiko [8 ]
Oji, Yusuke [1 ]
机构：
[1] Osaka Univ, CLBS, Grad Sch Med, Osaka, Japan
[2] Osaka Univ, NeuroSurg, Grad Sch Med, Osaka, Japan
[3] Osaka Univ, Res Med Clin Imm, Grad Sch Med, Osaka, Japan
[4] Osaka Univ, Hematol Oncol, Grad Sch Med, Osaka, Japan
[5] Osaka Univ, Canc Immther, Grad Sch Med, Osaka, Japan
[6] Osaka Univ, Canc Stem Cell Biol, Grad Sch Med, Osaka, Japan
[7] Osaka Univ, Grad Sch Med, Osaka, Japan
[8] Osaka Univ, NeuroSurg, Grad Sch Med, Osaka, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P12-2-6
引用
收藏
页码：524 / 524
页数：1
相关论文
共 50 条
  • [21] Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
    Busse, Antonia
    Letsch, Anne
    Scheibenbogen, Carmen
    Nonnenmacher, Anika
    Ochsenreither, Sebastian
    Thiel, Eckhard
    Keilholz, Ulrich
    JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
  • [22] Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
    Antonia Busse
    Anne Letsch
    Carmen Scheibenbogen
    Anika Nonnenmacher
    Sebastian Ochsenreither
    Eckhard Thiel
    Ulrich Keilholz
    Journal of Translational Medicine, 8
  • [23] WT1 peptide cancer vaccine for patients with hematopoietic malignancies and solid cancers
    Oka, Yoshihiro
    Tsuboi, Akihiro
    Elisseeva, Olga A.
    Nakajima, Hiroko
    Fujiki, Fumihiro
    Kawakami, Manabu
    Shirakata, Toshiaki
    Nishida, Sumiyuki
    Hosen, Naoki
    Oji, Yusuke
    Kawase, Ichiro
    Sugiyama, Haruo
    THESCIENTIFICWORLDJOURNAL, 2007, 7 : 649 - 665
  • [24] Phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome
    Ueda, Yasunori
    Ogura, Michinori
    Miyakoshi, Shigesaburo
    Suzuki, Takahiro
    Heike, Yuji
    Tagashira, Shuzo
    Tsuchiya, Satoru
    Ohyashiki, Kazuma
    Miyazaki, Yasushi
    CANCER SCIENCE, 2017, 108 (12): : 2445 - 2453
  • [25] A Phase 1/2 Study of WT1 Peptide Cancer Vaccine WT4869 in Patients with Myelodysplastic Syndromes (MDS)
    Suzuki, Takahiro
    Ueda, Yasunori
    Ogura, Michinori
    Uchida, Toshiki
    Ozawa, Keiya
    Miyakoshi, Shigesaburo
    Naoe, Tomoki
    Murata, Makoto
    Kizaki, Masahiro
    Uike, Naokuni
    Abe, Yasunobu
    Hidaka, Michihiro
    Tagashira, Shuzo
    Tsuchiya, Satoru
    Ohyashiki, Kazuma
    Miyazaki, Yasushi
    BLOOD, 2015, 126 (23)
  • [26] Wilms Tumor Gene ( WT1) Peptide- based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer
    Nishida, Sumiyuki
    Koido, Shigeo
    Takeda, Yutaka
    Homma, Sadamu
    Komita, Hideo
    Takahara, Akitaka
    Morita, Satoshi
    Ito, Toshinori
    Morimoto, Soyoko
    Hara, Kazuma
    Tsuboi, Akihiro
    Oka, Yoshihiro
    Yanagisawa, Satoru
    Toyama, Yoichi
    Ikegami, Masahiro
    Kitagawa, Toru
    Eguchi, Hidetoshi
    Wada, Hiroshi
    Nagano, Hiroaki
    Nakata, Jun
    Nakae, Yoshiki
    Hosen, Naoki
    Oji, Yusuke
    Tanaka, Toshio
    Kawase, Ichiro
    Kumanogoh, Atsushi
    Sakamoto, Junichi
    Doki, Yuichiro
    Mori, Masaki
    Ohkusa, Toshifumi
    Tajiri, Hisao
    Sugiyama, Haruo
    JOURNAL OF IMMUNOTHERAPY, 2014, 37 (02) : 105 - 114
  • [27] Reader-free ELISPOT assay for immuno-monitoring in peptide-based cancer vaccine immunotherapy
    Hayashi, Sae
    Imanishi, Rin
    Adachi, Mayuko
    Ikejima, Sayaka
    Nakata, Jun
    Morimoto, Soyoko
    Fujiki, Fumihiro
    Nishida, Sumiyuki
    Tsuboi, Akihiro
    Hosen, Naoki
    Nakajima, Hiroko
    Hasegawa, Kana
    Oka, Yoshihiro
    Sugiyama, Haruo
    Oji, Yusuke
    BIOMEDICAL REPORTS, 2020, 12 (05) : 244 - 250
  • [28] Biomarkers predictive of overall survival in advanced cancer patients treated with a peptide-based cancer vaccine
    Suekane, S.
    Noguchi, M.
    Terasaki, M.
    Yutani, S.
    Narita, Y.
    Yamada, A.
    Shichijo, S.
    Igawa, T.
    Itoh, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
    Uttenthal, Benjamin
    Martinez-Davila, Irma
    Ivey, Adam
    Craddock, Charles
    Chen, Frederick
    Virchis, Andras
    Kottaridis, Panagiotis
    Grimwade, David
    Khwaja, Asim
    Stauss, Hans
    Morris, Emma C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (03) : 366 - 375
  • [30] Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy
    Ota, Shuichi
    Miyashita, Mamiko
    Yamagishi, Yuka
    Ogasawara, Masahiro
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (12) : 5563 - 5572
12345